<div id="readability-page-1">11:14 AM EST, 12/24/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.18% to 1,686.51 on the S&amp;P Europe Select ADR Index.From continental Europe, the gainers were led by furniture manufacturer Natuzzi (NTZ) and biotech firm Evaxion ( EVAX ) , which rose 2.5% and 2.4% respectively. They were followed by pharmaceutical company Ascendis Pharma ( ASND ) and medical device maker EDAP TMS ( EDAP ) , which were up 2.3% and 2.1% respectively.The decliners from continental Europe were led by internet advertising firm Criteo ( CRTO ) and semiconductor company Sequans Communications ( SQNS ) , which fell 2.4% and 2.3% respectively. They were followed by oil and gas company TotalEnergies (TTE) and biopharmaceutical company Grifols ( GRFS ) , which were down 0.4% and 0.2% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and biotech firm Autolus Therapeutics ( AUTL ) , which advanced 7.2% and 1.5% respectively. They were followed by biopharmaceutical company NuCana ( NCNA ) and 3D printer company Materialise (MTLS) and biopharmaceutical company Mereo BioPharma Group ( MREO ) , which increased 1.2% and 0.4% respectively.The decliners from the UK and Ireland were led by biotech company Trinity Biotech ( TRIB ) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which shed 13% and 8.8% respectively. They were followed by pharmaceutical company Silence Therapeutics ( SLN ) and 3D printer company Materialise (MTLS), which dropped 2.7% and 0.5% respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

BDRX

AUTL

European equities traded in the US as American depositary receipts rose 0.18% on the S&P Europe Select ADR Index. Notable gainers included Natuzzi and Evaxion, while Criteo and Sequans Communications led decliners. From the UK and Ireland, Akari Therapeutics and Autolus Therapeutics advanced, while Trinity Biotech and Biodexa Pharmaceuticals declined. MT Newswires does not provide investment advice.

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading